Phase I study of Zevalin (Ibritumomab Tiuxetan) in Waldenstrom's Macroglobulinemia (Lymphoplasmacytic lymphoma)

Click here to display the Athens 2002 Conference Overview

Click here to download the Athens 2002 Conference Program in PDF format.

Choose from the following list of conference sessions:

• Genetic Basis and Pathogenesis
• Monoclonal Gammopathies
• Defining Waldenstrom's Macroglobulinemia
• Prognostic Markers Waldenstrom's Macroglobulinemia
• Therapeutics in WM: Alkylator agents and nucleoside analogues
• Therapeutics in WM: Monoclonal Antibodies
• Therapeutics in WM: Thalidomide
• Therapeutics in WM: Transplant Therapy
• Therapeutics in WM: Novel Therapeutic Strategies
• Pathogenesis and therapy of IgM related complications

Click here to display the Athens 2002 Photo Gallery

Click here to display the Athens 2002 Video Gallery

Click on the following links to display the corresponding Consensus Panel report in PDF format:

• Consensus Panel One: Clinicopathological Definition of WM
• Consensus Panel Two: Prognostic Markers and Citeria to Treat WM
• Consensus Panel Three: Treament Recommendations in WM
• Consensus Panel Four: Uniform Response Criterion in WM

Click here to display the list of Athens 2002 Sponsors